Alzheimer's Assocation Research only
All of alz.org
  • Go to Alz.org
  • Research Center
  • AAIC
  • ISTAART
  • Journal
  • Grants
  • TrialMatch
  • Press
  • Donate
  • Contact Us
Home
Science and Progress
Clinical Trials
Funding and Collaboration
You can Help
Stay Current
Video and Resources

Text Size

Small text Medium text Large text

Already have an account? Log in.

Why Participate in a Clinical Trial


Overview


Without clinical trials, there can be no better treatments, no prevention and no cure for Alzheimer's disease. Scientists work constantly to find enhanced ways to treat diseases, but improved treatments can never become a reality without testing in clinical trials with human volunteers.

Individuals with dementia or those who are at risk of developing it, caregivers and healthy volunteers with no dementia issues are urgently needed to participate in more than 250 actively enrolling clinical trials focused on Alzheimer's and other dementias. Recruiting and retaining trial participants is now the greatest obstacle, other than funding, to developing the next generation of Alzheimer's treatments.

By participating in clinical research, you can help to accelerate progress and provide valuable insight into potential treatments and methods of prevention. Get started with Alzheimer’s Association TrialMatch®, a free, easy-to-use clinical studies matching service that generates customized lists of studies based on user-provided information.

Benefits of clinical trials


Participating in clinical trials has the potential to help both the individual participant and other individuals who have Alzheimer's or are at risk of developing it.

  • You can play a more active role in your own health care.
  • You can gain access to potential treatments before they are widely available.
  • You can receive expert medical care at leading healthcare facilities — often free of cost — while participating in important medical research.
  • You can help future generations by contributing to Alzheimer's research.

Back to top

Risks of participation


Patient safety is the most important aspect of every Alzheimer's disease clinical trial. The procedures for each study are reviewed by an expert committee not directly involved in the trial, helping ensure that patient safety is protected.

There are risks, however, to clinical trials:

  • There may be unpleasant or even serious side effects related to the potential treatment(s) being studied.
  • The experimental treatment may not be effective.

Details of risks related to participation in the clinical study are spelled out in the consent form participants (or their proxies) sign when they agree to participate.

Reasons for optimism


No new treatment advances to the clinical testing phase unless there is strong evidence indicating it will be as effective as, or more effective than, currently available therapies. Every clinical trial contributes valuable knowledge, whether or not the treatment works as hoped.

Participating in clinical studies gives us optimism for today and promise for the future. They provide many participants with access to cutting-edge treatments and expert medical care. And some day they will lead us to the end of Alzheimer’s.

Sign up for our weekly e-newsletter
Stay up-to-date on the latest advances in Alzheimer's treatments, care and research. Subscribe now

Participants receive a high standard of care


All participants receive regular care related to the trial and opportunities to talk to clinical trial staff. Research shows that people living with the disease who are involved in clinical trials tend to do somewhat better than people in a similar stage of their disease who are not enrolled in clinical trials, regardless of whether the experimental treatment works. Scientists believe this advantage may be due to the general high quality of care provided during clinical trials.

Get started today by registering with Alzheimer’s Association TrialMatch, a free, easy-to-use clinical studies matching service that generates customized lists of studies based on user-provided information.



Alzheimer's Association International Conference | July 16-20, 2017, London, England

Abstract Submissions Now Open

The Scientific Program Committee is now accepting submissions for poster
presentations, oral presentations and featured research sessions.